Molecular foundation of anxiety disorders

Journal of Neural Transmission

Volumn 108, Issue 6, 2001, Pages 717-746

  Lesch, K P ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Anxiety; Anxiety disorders; Gene knockout; Genetics; Molecular mechanism

Indexed keywords

ANIMAL MODEL; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; HEREDITY; MOLECULAR GENETICS; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; OBSESSION; PANIC; PHENOTYPE; PHOBIA; PRIORITY JOURNAL;

ANIMALS; ANXIETY DISORDERS; BRAIN CHEMISTRY; HUMANS;

EID: 0034913197     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020170048     Document Type: Article

References (154)

1. Segregation analysis of obsessive-compulsive disorder using symptom-based factor scores
2. Intact coding region of the serotonin transporter in obsessive-compulsive disorder
3. The genetics of six neurotic disorders: A twin study
4. Dopamine D4 receptor (D4DR) and serotonin transporter promoter (5-HTTLPR) polymorphisms in the determination of temperament in 2-month-old infants
5. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
6. Family history of anxiety disorders in control subjects with lactate-induced panic attacks
7. Age at onset of panic disorder: Influence of familial liability to the disease and of childhood separation anxiety disorder
8. Anxiety and social exclusion
9. Epidemiology of obsessive-compulsive disorder
10. Psychiatric disorders in the families of patients with obsessive-compulsive disorder
11. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice
12. Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder
13. Early experience and serotonin transporter gene variation interact to influence primate CNS function
14. Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene
15. Investigation of dopamine system genes in obsessive-compulsive disorder
16. A family study of obsessive-compulsive disorder
17. Regressive logistic models for familial disease and other binary traits
18. Genes, environment and personality
19. Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorder
20. The nature of generalized anxiety disorder and pathological worry: Current evidence and conceptual models
21. Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice
22. Evolutionary personality psychology
23. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA
24. Complex segregation analysis of obsessive-compulsive disorder in 141 families of eating disorder probands, with and without obsessive-compulsive disorder
25. Serotonin transporter gene polymorphism and neurobehavioral development in rhesus monkey neonates
26. A functional neuroanatomy of anxiety and fear: Implications for the pathophysiology and treatment of anxiety disorders
27. Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II
28. Genetic and environmental influences on obsessional traits and symptoms
29. A novel functional polymorphism within the promoter of the serotonin transporter gene: Possible role in susceptibility to affective disorders
30. Initial sequencing and analysis of the human genome
31. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1
32. Occurrence of the Cys311 DRD2 variant in a pedigree multiply affected with panic disorder
33. Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests
34. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice
35. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues
36. Panic disorder: Genetic considerations
37. Close linkage between panic disorder and alpha-haptoglobin excluded in 10 families
38. Candidate gene study of eight GABAA receptor subunits in panic disorder
39. Genomewide survey of panic disorder
40. Functional promoter polymorphism of the human serotonin transporter: Lack of association with panic disorder
41. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease
42. Systematic screening for mutations in the coding region of the 5-HTT gene using PCR and DGGE
43. Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli
44. Panic and panic disorder in the United States
45. Dopamine D4 receptor and serotonin transporter promoter in the determination of neonatal temperament
46. Genetic analyses of emotionality
47. Exploring the covariation between anxiety and depression symptoms: A genetic analysis of the effects of age and sex
48. Serotonin transporter promoter polymorphism influences topography of inhibitory motor control
49. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses
50. A simple genetic basis for a complex psychological trait in laboratory mice
51. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior
52. Familial aggregation and phenomenology of "early"-onset (at or before age 20 years) panic disorder
53. Neuroanatomical hypothesis of panic disorder, revised
54. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample
55. Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder
56. Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder
57. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice
58. CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys
59. A longitudinal assessment of CSF monoamine metabolite and plasma cortisol concentrations in young rhesus monkeys
60. A family study of panic disorder
61. A family study of panic disorder: Reanalysis using a regressive logistic model that incorporates a sibship environment
62. Studies of a neurochemical link between depression, anxiety, and stress from (3H) imipramine and (3H) paroxetine binding on human platelets
63. An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population
64. Temperamental contributions to social behavior
65. Biological bases of childhood shyness
66. m-chlorophenylpiperazine as a probe of serotonin function
67. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder
68. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase
69. Missense mutation of the cholecystokinin B receptor gene: Lack of association with panic disorder
70. Major depression and generalised anxiety disorder. Same genes, (partly) different environments - Revisited
71. Generalized anxiety disorder in women. A population-based twin study
72. Major depression and generalized anxiety disorder. Same genes, (partly) different environments?
73. The prediction of major depression in women: Toward an integrated etiologic model
74. A longitudinal twin study of personality and major depression in women
75. Panic disorder in women: A population-based twin study
76. Stressful life events, genetic liability, and onset of an episode of major depression in women
77. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism
78. A twin-family study of self-report symptoms of panic-phobia and somatization
79. Fears and phobias: Reliability and heritability
80. Investigation of cholecystokinin system genes in panic disorder
81. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey
82. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
83. Results of a genome-wide genetic screen for panic disorder
84. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice
85. The influence of a targeted deletion of the IFNgamma gene on emotional behaviors
86. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
87. Psychiatric disorders in first degree relatives of children and adolescents with obsessive compulsive disorder
88. Tics and Tourette's disorder: A 2- to 7-year follow-up of 54 obsessive-compulsive children
89. 5-HT1A receptor inactivation: Anxiety or depression as a murine experience
90. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
91. Serotonin transporter, personality, and behavior: Toward dissection of gene-gene and gene-environment interaction
92. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: Gender and brain region differences
93. Phenotypic and genetic structure of traits delineating personality disorder
94. Lifetime prevalence of mood and anxiety disorders in twin pairs discordant for schizophrenia
95. The familial relationship between panic disorder and unipolar depression
96. Altered emotional and locomotor responses in mice deficient in the transcription factor CREM
97. Anxiety disorders and neuroticism: Are there genetic factors specific to panic?
98. Serotonin transporter gene regulatory region polymorphism and panic disorder
99. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder
100. Genetic and environmental influences on human behavioral differences
101. The familial occurrence of agoraphobia
102. Temperament and early environment influence comorbidity and personality disorders in major depression
103. Exclusion of the tyrosine hydroxylase gene in 14 panic disorder pedigrees
104. Serotonin transporter gene regulatory region polymorphism and anxiety-related traits in the Japanese
105. Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour
106. No association between anxiety disorders and catechol-O-methyltransferase polymorphism
107. Avoidant personality disorder and taijin kyoufu: Socio-cultural implications of the WHO/ADAMHA international study of personality disorders in Japan
108. Anxious traits, anxious attachment, and anxious-cluster personality disorders
109. Increased anxiety of mice lacking the serotonin1A receptor
110. A family study of obsessive-compulsive disorder
111. (Over)correction of FMR1 deficiency with YAC transgenics: Behavioral and physical features
112. Family history of panic disorder and hypersensitivity to CO2 in patients with panic disorder
113. Panic attacks: A twin study
114. Barrel pattern formation in somatosensory cortical layer IV requires serotonin uptake by thalamocortical endings, while vesicular monoamine release is necessary for development of supragranular layers
115. Effects of acute and repeated ethanol exposures on the locomotor activity of BXD recombinant inbred mice
116. The genetic basis of complex human behaviors
117. Hypothalamic-pituitary-adrenal dysfunction in Apoe(-/-) mice: Possible role in behavioral and metabolic alterations
118. Serotonin receptor 1A knockout: An animal model of anxiety-related disorder
119. Stress and emotionality: A multidimensional and genetic approach
120. Genetic studies of obsessive compulsive disorder
121. Sodium lactate response and familial risk for panic disorder
122. Obsessive compulsive disorder in children and adolescents: Phenomenology and family history
123. The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children
124. A twin study of generalized anxiety disorder and major depression
125. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase A and 5-HT transporter knock-out mice
126. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function
127. Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice
128. Obsessive compulsive disorder and mood disorders: A family study
129. Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety
130. A family study of anxiety disorders: Familial transmission and relationship to mood disorder and psychoactive substance use disorder
131. Neurobiology of the obsessive-compulsive spectrum disorders
132. Neurobiological perspectives on social phobia: From affiliation to zoology
133. Genetic linkage to the serotonin transporter protein and 5HT2A receptor genes excluded in generalized social phobia
134. D3 dopamine receptor-deficient mouse: Evidence for reduced anxiety
135. Anxiety and increased 5-HT1A receptor response in NCAM null mutant mice
136. Postnatal development of a GABA deficit and disturbance of neural functions in mice lacking GAD65
137. Genes and aggressiveness. Behavioral genetics
138. Personality similarity in twins reared apart and together
139. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1
140. Genetic factors in anxiety disorders
141. Comorbidity of major depression and anxiety disorders in twin pairs
142. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety
143. Role of the 5-HT transporter and the 5-HT1B receptor on the patterning of retinal fibres in the lateral geniculate nucleus and the superior colliculus
144. Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder
145. Adrenergic receptor genes as candidate genes for panic disorder: A linkage study
146. Panic and generalized anxiety: Are they separate disorders?
147. Family genetic studies of panic disorder
148. The cross-national epidemiology of panic disorder
149. Mechanisms mediating the increased anxiety-like behavior and excessive responses to stress in mice lacking the serotonin transporter
150. Anxiety disorders: Similarities and differences of comorbidity in treated and untreated groups
151. Disability and quality of life in pure and comorbid social phobia. Findings from a controlled study
152. The genetics of panic disorder and generalized anxiety disorder
153. Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors